Home > National Drug Code (NDC) > CLENZIDERM PORE THERAPY

CLENZIDERM PORE THERAPY - 62032-110-60 - (SALICYLIC ACID)

Alphabetical Index


Drug Information of CLENZIDERM PORE THERAPY

Product NDC: 62032-110
Proprietary Name: CLENZIDERM PORE THERAPY
Non Proprietary Name: SALICYLIC ACID
Active Ingredient(s): 20    mg/mL & nbsp;   SALICYLIC ACID
Administration Route(s): TOPICAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of CLENZIDERM PORE THERAPY

Product NDC: 62032-110
Labeler Name: OMP, INC.
Product Type: HUMAN OTC DRUG
FDA Application Number: part333D
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20070201

Package Information of CLENZIDERM PORE THERAPY

Package NDC: 62032-110-60
Package Description: 118 mL in 1 BOTTLE, PLASTIC (62032-110-60)

NDC Information of CLENZIDERM PORE THERAPY

NDC Code 62032-110-60
Proprietary Name CLENZIDERM PORE THERAPY
Package Description 118 mL in 1 BOTTLE, PLASTIC (62032-110-60)
Product NDC 62032-110
Product Type Name HUMAN OTC DRUG
Non Proprietary Name SALICYLIC ACID
Dosage Form Name LIQUID
Route Name TOPICAL
Start Marketing Date 20070201
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name OMP, INC.
Substance Name SALICYLIC ACID
Strength Number 20
Strength Unit mg/mL
Pharmaceutical Classes

Complete Information of CLENZIDERM PORE THERAPY


General Information